Craft

Pasithea Therapeutics

Stock Price

$3.9

2024-10-29

Market Capitalization

$4.1 M

2024-10-29

Revenue

$486.6 K

FY, 2022

Pasithea Therapeutics Summary

Company Summary

Overview
Pasithea Therapeutics is a biotechnology company focused on the research and discovery of treatments for psychiatric and neurological disorders. The company conducts research in the intravenous administration of ketamine to treat depression and PTSD. The company also provides business support services to anti-depression clinics.
Type
Public
Status
Active
Founded
2020
HQ
Los Angeles, CA, US | view all locations
Website
https://pasitheaclinics.com/
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Los Angeles, CA HQ

    United States

    2110 Narcissus Ct, Venice

Pasithea Therapeutics Financials

Summary Financials

Net income (Q1, 2026)
($2.9M)
Cash (Q1, 2026)
$50.4M
EBIT (Q1, 2026)
($4.9M)

Footer menu